Restasis (cyclosporine ophthalmic emulsion) is a prescription drug that’s used to treat dry eye syndrome. The drug comes as an emulsion (oily liquid). You usually apply 1 drop into each affected eye ...

The Food and Drug Administration has approved the first generic version of AbbVie Inc.’s dry-eye drug Restasis, or cyclosporine ophthalmic emulsion (eye drops). The generic cyclosporine ophthalmic ...

If you have chronic (long-term) dry eye, your doctor might suggest treatment with Xiidra or Restasis. They’re both prescription medications prescribed to treat chronic dry eye (also called dry eye ...

Please provide your email address to receive an email when new articles are posted on . Allergan announced it has received FDA approval for Restasis Multidose, a preservative-free, multidose bottle ...

It’s not exactly going to be smooth sailing for Allergan’s multidose bottle version of dry-eye med Restasis. As it finally gets the green light from the FDA, a new challenge named Xiidra lies ahead.

The Food and Drug Administration has approved Mylan’s generic Restasis (cyclosporine ophthalmic emulsion) 0.05% single-use vials (eye drops) to increase tear production in patients whose tear ...

Credit: Getty Images. Cyclosporine ophthalmic emulsion is indicated to increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associated ...

RESTASIS (Cyclosporine) 0.05% ophthalmic emulsion from Allergan Restasis (cyclosporine 0.05%, from Allergan) ophthalmic emulsion is now available in a 60-count package (two trays of 30 vials) that ...

-- New Delivery System Will Now Provide RESTASIS ® in a Preservative Free, Easy-to-Use, Multi-Dose Bottle-- -- RESTASIS the Only* Health Canada Approved Treatment to Help Patients Produce More of ...

(RTTNews) - Amneal Pharmaceuticals, Inc. (AMRX) on Tuesday announced that the U.S. Food and Drug Administration has approved its cyclosporine ophthalmic emulsion 0.05%, a sterile formulation supplied ...